STAGE IIB PROSTATE CANCER
Clinical trials for STAGE IIB PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB PROSTATE CANCER trials appear
Sign up with your email to follow new studies for STAGE IIB PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a depression drug fight prostate cancer?
Disease control CompletedThis phase 2 trial tested phenelzine sulfate (Nardil), an antidepressant, in 26 men with prostate cancer that returned after initial treatment but hadn't spread. The goal was to see if the drug could lower PSA levels, a marker of cancer activity. Researchers measured how many pat…
Matched conditions: STAGE IIB PROSTATE CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Glow-in-the-Dark antibody could help surgeons spot prostate cancer
Knowledge-focused CompletedThis early-phase trial tested a fluorescent antibody that attaches to prostate cancer cells. Seven men with moderate- to high-risk prostate cancer received the antibody before robotic prostate removal surgery. The goal was to see if the glowing antibody could help surgeons identi…
Matched conditions: STAGE IIB PROSTATE CANCER
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Black raspberries under the microscope for prostate cancer prevention
Knowledge-focused CompletedThis early-phase trial studied how compounds from black raspberries are absorbed and processed in 60 men with prostate cancer who were scheduled for surgery. Participants ate a black raspberry confection and followed a special diet before surgery. The goal was not to treat cancer…
Matched conditions: STAGE IIB PROSTATE CANCER
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC